Skip to content
GCC AI Research

Search

Results for "Drug treatments"

Alumni Focus: Sara Althubaiti

KAUST ·

KAUST alumna Sara Althubaiti (M.S. '18) is now a computer science Ph.D. student in the Bio-Ontology Research Group, focusing on using AI to prioritize cancer mutations and predict new disease treatments. Her work involves understanding the relationship between drug side effects and disease phenotypes. Althubaiti aims to continue in academia after her Ph.D., contributing to research in Saudi universities. Why it matters: This highlights KAUST's role in fostering local talent and contributing to advancements in AI-driven healthcare research within the Kingdom.

Exploring brain-energy metabolism

KAUST ·

KAUST researchers are exploring the link between nutrition and brain-energy metabolism to address cognitive decline, dementia, and Alzheimer’s disease. Dr. Pierre Magistretti and Dr. Johannes le Coutre are collaborating on ways to merge brain-energy metabolism research into the field of nutrition. They published an article entitled “Goals in Nutrition Science 2015-2020” in the journal Frontiers in Nutrition. Why it matters: This research could lead to nutritional interventions to hinder or prevent cognitive decline, offering a new approach beyond traditional drug treatments.